Wednesday, March 21, 2018

Gavi applauds MSF’s effort to break Pfizer vaccine monopoly in India

Anuradha Gupta, Deputy CEO of the vaccine alliance Gavi, says Médecins Sans Frontières (MSF)’s legal challenge of a Pfizer patent in India could, if successful, contribute to making the pharmaceutical market more “healthy.” Revoking the patent would break Pfizer’s monopoly on pneumonia vaccine, opening the way for cheaper generic copies to enter the market.

Anuradha Gupta, Deputy CEO of Gavi
Photo: Gavi

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.